Short sellers turned aggressive this week. The latest ORTEX data shows clear patterns — semiconductors, biotech, and a private-prison play all saw notable increases.
WOLF sits at 85.2% SI of free float — up 6.9 percentage points in just seven days. That's one of the largest week-on-week jumps among mid-cap US names. Availability has hit zero, meaning new short positions are nearly impossible to open. The semiconductor firm has dropped 55% in three months.
REPL (Replimune) saw its SI jump 10.4 points to 37.9% this week. GALT (Galectin Therapeutics) stays stubbornly high at 68.9% SI, with a short score of 90. Cost to borrow on BYND (Beyond Meat) sits at 89.5% APR — bears are paying a steep price to stay short.
CXW (CoreCivic) saw SI surge from 2.4% to 10.0% in a week — a fourfold rise. The private prison operator drew fresh attention amid ongoing policy headlines.
PYPL grabbed headlines after reports of a Stripe and Advent takeover approach. Short interest remains contained at 4.4%. ENVX (Enovix) has near-peak utilization at 98.6% with SI at 23.9% — lenders are nearly fully deployed.
This is not financial advice.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
